Behcet Disease Drug Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281506 No. of Pages: 74 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Behcet Disease Drug in global, including the following market information:
Global Behcet Disease Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Behcet Disease Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Behcet Disease Drug companies in 2021 (%)
The global Behcet Disease Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adalimumab Biosimilar Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Behcet Disease Drug include AbbVie Inc, Celgene Corp, Cell Medica Ltd, Coherus BioSciences Inc, Genor BioPharma Co Ltd, Novartis AG, Panacea Biotec Ltd and R Pharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Behcet Disease Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Behcet Disease Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Behcet Disease Drug Market Segment Percentages, by Type, 2021 (%)
Adalimumab Biosimilar
Apremilast
Canakinumab
Infliximab Biosimilar
Others
Global Behcet Disease Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Behcet Disease Drug Market Segment Percentages, by Application, 2021 (%)
Home Care
Hospital
Clinic
Global Behcet Disease Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Behcet Disease Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Behcet Disease Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Behcet Disease Drug revenues share in global market, 2021 (%)
Key companies Behcet Disease Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Behcet Disease Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc
Celgene Corp
Cell Medica Ltd
Coherus BioSciences Inc
Genor BioPharma Co Ltd
Novartis AG
Panacea Biotec Ltd
R Pharm
1 Introduction to Research & Analysis Reports
1.1 Behcet Disease Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Behcet Disease Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Behcet Disease Drug Overall Market Size
2.1 Global Behcet Disease Drug Market Size: 2021 VS 2028
2.2 Global Behcet Disease Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Behcet Disease Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Behcet Disease Drug Players in Global Market
3.2 Top Global Behcet Disease Drug Companies Ranked by Revenue
3.3 Global Behcet Disease Drug Revenue by Companies
3.4 Global Behcet Disease Drug Sales by Companies
3.5 Global Behcet Disease Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Behcet Disease Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Behcet Disease Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Behcet Disease Drug Players in Global Market
3.8.1 List of Global Tier 1 Behcet Disease Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Behcet Disease Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Behcet Disease Drug Market Size Markets, 2021 & 2028
4.1.2 Adalimumab Biosimilar
4.1.3 Apremilast
4.1.4 Canakinumab
4.1.5 Infliximab Biosimilar
4.1.6 Others
4.2 By Type - Global Behcet Disease Drug Revenue & Forecasts
4.2.1 By Type - Global Behcet Disease Drug Revenue, 2017-2022
4.2.2 By Type - Global Behcet Disease Drug Revenue, 2023-2028
4.2.3 By Type - Global Behcet Disease Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Behcet Disease Drug Sales & Forecasts
4.3.1 By Type - Global Behcet Disease Drug Sales, 2017-2022
4.3.2 By Type - Global Behcet Disease Drug Sales, 2023-2028
4.3.3 By Type - Global Behcet Disease Drug Sales Market Share, 2017-2028
4.4 By Type - Global Behcet Disease Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Behcet Disease Drug Market Size, 2021 & 2028
5.1.2 Home Care
5.1.3 Hospital
5.1.4 Clinic
5.2 By Application - Global Behcet Disease Drug Revenue & Forecasts
5.2.1 By Application - Global Behcet Disease Drug Revenue, 2017-2022
5.2.2 By Application - Global Behcet Disease Drug Revenue, 2023-2028
5.2.3 By Application - Global Behcet Disease Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Behcet Disease Drug Sales & Forecasts
5.3.1 By Application - Global Behcet Disease Drug Sales, 2017-2022
5.3.2 By Application - Global Behcet Disease Drug Sales, 2023-2028
5.3.3 By Application - Global Behcet Disease Drug Sales Market Share, 2017-2028
5.4 By Application - Global Behcet Disease Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Behcet Disease Drug Market Size, 2021 & 2028
6.2 By Region - Global Behcet Disease Drug Revenue & Forecasts
6.2.1 By Region - Global Behcet Disease Drug Revenue, 2017-2022
6.2.2 By Region - Global Behcet Disease Drug Revenue, 2023-2028
6.2.3 By Region - Global Behcet Disease Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Behcet Disease Drug Sales & Forecasts
6.3.1 By Region - Global Behcet Disease Drug Sales, 2017-2022
6.3.2 By Region - Global Behcet Disease Drug Sales, 2023-2028
6.3.3 By Region - Global Behcet Disease Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Behcet Disease Drug Revenue, 2017-2028
6.4.2 By Country - North America Behcet Disease Drug Sales, 2017-2028
6.4.3 US Behcet Disease Drug Market Size, 2017-2028
6.4.4 Canada Behcet Disease Drug Market Size, 2017-2028
6.4.5 Mexico Behcet Disease Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Behcet Disease Drug Revenue, 2017-2028
6.5.2 By Country - Europe Behcet Disease Drug Sales, 2017-2028
6.5.3 Germany Behcet Disease Drug Market Size, 2017-2028
6.5.4 France Behcet Disease Drug Market Size, 2017-2028
6.5.5 U.K. Behcet Disease Drug Market Size, 2017-2028
6.5.6 Italy Behcet Disease Drug Market Size, 2017-2028
6.5.7 Russia Behcet Disease Drug Market Size, 2017-2028
6.5.8 Nordic Countries Behcet Disease Drug Market Size, 2017-2028
6.5.9 Benelux Behcet Disease Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Behcet Disease Drug Revenue, 2017-2028
6.6.2 By Region - Asia Behcet Disease Drug Sales, 2017-2028
6.6.3 China Behcet Disease Drug Market Size, 2017-2028
6.6.4 Japan Behcet Disease Drug Market Size, 2017-2028
6.6.5 South Korea Behcet Disease Drug Market Size, 2017-2028
6.6.6 Southeast Asia Behcet Disease Drug Market Size, 2017-2028
6.6.7 India Behcet Disease Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Behcet Disease Drug Revenue, 2017-2028
6.7.2 By Country - South America Behcet Disease Drug Sales, 2017-2028
6.7.3 Brazil Behcet Disease Drug Market Size, 2017-2028
6.7.4 Argentina Behcet Disease Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Behcet Disease Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Behcet Disease Drug Sales, 2017-2028
6.8.3 Turkey Behcet Disease Drug Market Size, 2017-2028
6.8.4 Israel Behcet Disease Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Behcet Disease Drug Market Size, 2017-2028
6.8.6 UAE Behcet Disease Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 AbbVie Inc
7.1.1 AbbVie Inc Corporate Summary
7.1.2 AbbVie Inc Business Overview
7.1.3 AbbVie Inc Behcet Disease Drug Major Product Offerings
7.1.4 AbbVie Inc Behcet Disease Drug Sales and Revenue in Global (2017-2022)
7.1.5 AbbVie Inc Key News
7.2 Celgene Corp
7.2.1 Celgene Corp Corporate Summary
7.2.2 Celgene Corp Business Overview
7.2.3 Celgene Corp Behcet Disease Drug Major Product Offerings
7.2.4 Celgene Corp Behcet Disease Drug Sales and Revenue in Global (2017-2022)
7.2.5 Celgene Corp Key News
7.3 Cell Medica Ltd
7.3.1 Cell Medica Ltd Corporate Summary
7.3.2 Cell Medica Ltd Business Overview
7.3.3 Cell Medica Ltd Behcet Disease Drug Major Product Offerings
7.3.4 Cell Medica Ltd Behcet Disease Drug Sales and Revenue in Global (2017-2022)
7.3.5 Cell Medica Ltd Key News
7.4 Coherus BioSciences Inc
7.4.1 Coherus BioSciences Inc Corporate Summary
7.4.2 Coherus BioSciences Inc Business Overview
7.4.3 Coherus BioSciences Inc Behcet Disease Drug Major Product Offerings
7.4.4 Coherus BioSciences Inc Behcet Disease Drug Sales and Revenue in Global (2017-2022)
7.4.5 Coherus BioSciences Inc Key News
7.5 Genor BioPharma Co Ltd
7.5.1 Genor BioPharma Co Ltd Corporate Summary
7.5.2 Genor BioPharma Co Ltd Business Overview
7.5.3 Genor BioPharma Co Ltd Behcet Disease Drug Major Product Offerings
7.5.4 Genor BioPharma Co Ltd Behcet Disease Drug Sales and Revenue in Global (2017-2022)
7.5.5 Genor BioPharma Co Ltd Key News
7.6 Novartis AG
7.6.1 Novartis AG Corporate Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Behcet Disease Drug Major Product Offerings
7.6.4 Novartis AG Behcet Disease Drug Sales and Revenue in Global (2017-2022)
7.6.5 Novartis AG Key News
7.7 Panacea Biotec Ltd
7.7.1 Panacea Biotec Ltd Corporate Summary
7.7.2 Panacea Biotec Ltd Business Overview
7.7.3 Panacea Biotec Ltd Behcet Disease Drug Major Product Offerings
7.7.4 Panacea Biotec Ltd Behcet Disease Drug Sales and Revenue in Global (2017-2022)
7.7.5 Panacea Biotec Ltd Key News
7.8 R Pharm
7.8.1 R Pharm Corporate Summary
7.8.2 R Pharm Business Overview
7.8.3 R Pharm Behcet Disease Drug Major Product Offerings
7.8.4 R Pharm Behcet Disease Drug Sales and Revenue in Global (2017-2022)
7.8.5 R Pharm Key News
8 Global Behcet Disease Drug Production Capacity, Analysis
8.1 Global Behcet Disease Drug Production Capacity, 2017-2028
8.2 Behcet Disease Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Behcet Disease Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Behcet Disease Drug Supply Chain Analysis
10.1 Behcet Disease Drug Industry Value Chain
10.2 Behcet Disease Drug Upstream Market
10.3 Behcet Disease Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Behcet Disease Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com